Faculty

Institution

Unit

Venue

Paul Insel

Distinguished Professor Emeritus Distinguished Professor Emeritus of Pharmacology and Medicine

University of California, San Diego

Affiliations

School Of Medicine

Pharmacology

Paul Insel is currently serving as a Pharmacology Distinguished Professor Emeritus Distinguished Professor Emeritus of Pharmacology and Medicine at University of California, San Diego.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Paul Insel

University of California, San Diego

Distinguished Professor Emeritus Distinguished Professor Emeritus of Pharmacology and Medicine

You can click a keyword to filter the displayed items

pharmacology molecular biology cell biology receptors biochemistry cell signaling medicinal research vascular biology signal transduction membrane biology cardiology protein science receptor (biochemistry) gene expression g protein-coupled receptor cellular physiology cardiovascular research biological chemistry molecular physiology neuropharmacology endocrinology enzyme inhibition pharmacotherapy respiratory medicine pharmacological research circulatory physiology inhibitory activity cell physiology liver physiology signaling pathways renal function cardiovascular physiology experimental pharmacology cardiac muscle cardiovascular pharmacology molecular regulation mammalian biology renal pathophysiology clinical pharmacology lymphoid neoplasia beta-adrenergic receptors apoptosis protein phosphorylation thrombosis neuropsychopharmacology hormonal receptor cardiac fibroblasts blood platelet cell regulation adrenal disease receptor tyrosine kinases vascular pharmacology functional regulation adrenal glands therapeutic efficacy kidney research pharmacological studies adrenergic receptors key site blood pressure adenylate cyclase in vivo systems cyclic amp mdck cells endocrine hypertension platelet antagonist adenylyl cyclase b-adrenergic receptors lipid rafts human platelets atp release receptor number lymphoid cells cholera toxin experimental design myocardial ischemia gastrointestinal peptide hormone inflammation pancreatic cancer immunology molecular pharmacology heterotrimeric g proteins

Notable Scholarly Works

Notable Federal Grants

Collaborators

Introduction to the Theme “Novel Therapeutics With the Potential to Advance Health Care”. The Annual Review of Pharmacology and Toxicology (2024)

Paul A. InselSusan G. AmaraAmrita Ahluwalia

toxicologynovel therapeuticshealth carenovel therapiestherapeutic approachespharmacologypharmacotherapytherapeutic efficacy

Mindfulness Coaching With Digital Lifestyle Monitoring Enhances Selective Attention in Medical Scientists. medRxiv (Cold Spring Harbor Laboratory) (2024)

Satish JaiswalJason NanSuzanna R. PurpuraJames K. ManchandaIris Garcia-pakDhakshin S. RamanathanDawna ChussDeborah T. RanaEllen BeckPaul A. InselNeil ChiDavid M. RothHemal H. PatelJyoti Mishra

mental healthmedical scientistshealth informaticsattentionbehavioral medicinehealth technologymedicineapplied cognitive psychologyhealth sciencesbehavioral sciencesclinical psychology

Pancreatic Ductal Adenocarcinoma, β-Blockers, and Antihistamines: A Clinical Trial is Needed. Function (2024)

Jillian G BakerErica K SloanKevin PflegerPeter J McCormickCristina SalmerónPaul A Insel

pathologysurgical oncologydisease progressionpancreatic ductal adenocarcinomapharmacologyvascular biologytumor biologycancer immunotherapynovel therapiespancreatic canceroncogenesmedicinal researchcellular therapyurologyinflammationpancreatitispancreatic surgerytumor heterogeneityoncology

Bjp Recommendations for Publishing Research on Tobacco Smoke and Environmental Tobacco Smoke Exposure. British Journal of Pharmacology (2023)

RA PanettieriSC StanfordS AlexanderG CirinoCH GeorgePA Insel...

public healthtobacco smokeresearch ethicstobacco controlpharmacologybjp recommendationshealth sciences

Considering and Reporting Sex as an Experimental Variable II: An Update on Progress in the British Journal of Pharmacology. British Journal of Pharmacology (2023)

S. Clare StanfordSteve AlexanderGiuseppe CirinoChristopher H. GeorgePaul A. InselDave KendallYong JiReynold A. PanettieriHemal H. PatelChristopher G. SobeyBarbara StefanskaGary StephensMauro TeixeiraNathalie VergnollePéter FerdinandyAmrita Ahluwalia

experimental variable iiexperimental analysispharmacologysex differencesstatistics

Gpcr Signaling Measurement and Drug Profiling With an Automated Live-Cell Microscopy System. ACS Sensors (2023)

Eric GreenwaldClara PosnerAnanya BharathAnne LyonsCristina SalmerónKrishna SriramShu Z. WileyPaul A. InselJin Zhang

proteomicscell signalinghealth technologydrug profilingpharmacologysensor technologyinstrumentation

Introduction to the Theme “Pharmacological Individuality: New Insights and Strategies for Personalized and Precise Drug Treatment”. The Annual Review of Pharmacology and Toxicology (2023)

Urs A. MeyerSusan G. AmaraTerrence F. BlaschkePaul A. Insel

toxicologypharmacological individualitypharmacological studiesdrug treatmentpersonalized treatmentspharmacologypharmacological issueprecise drug treatmentclinical pharmacologypharmacotherapypharmacological researchpersonalized medicine

Isid1004 - Dermal Extracellular Matrix Inhibits Mast Cell Activation to Skin Commensal Bacteria. (2023)

Anna Di NardoShahrzad AlimohammadiKana Masuda-KurokiYu-Ling ChangPaul Insel

extracellular matrixcommensal bacteriadermatology

Mast Cell Tolerance in the Skin Microenvironment to Commensal Bacteria is Controlled by Fibroblasts. Cell Reports (2023)

Anna Di NardoYu-Ling ChangShahrzad AlimohammadiKana Masuda-KurokiZhenping WangKrishna SriramPaul A. Insel

microbiologybacteriacutaneous biologymast cell toleranceskin microenvironment

Ramipril for the Treatment of Covid-19: Ramic, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Advances in Therapy (2023)

Daniel Q. HuangVeeral AjmeraChristian TomaszewskiAndrew LaFreeRicki BettencourtWesley K. ThompsonDavey M. SmithAtul MalhotraRavindra L. MehtaVaishal ToliaJeffrey YinPaul A. InselStone LeachmanJinho JungSummer CollierLisa RichardsKristin WoodsMaral AmangurbanovaArchana BhattXinlian ZhangOana M. PenciuStuart ZarichTamrat RettaMichelle S. HarkinsJ. Pedro TeixeiraBrian ChinnockNetanya S. UtayJordan E. LakeRohit Loomba

infectious diseasesplacebo-controlled clinical trialhematologyantiviral therapypharmacologymedicinecovid-19pharmacotherapyclinical trials

1
2
3
4
5
58
10 / page

Paul Insel

Distinguished Professor Emeritus Distinguished Professor Emeritus of Pharmacology and Medicine

University of California, San Diego

Affiliations

School Of Medicine

Pharmacology

Paul Insel is currently serving as a Pharmacology Distinguished Professor Emeritus Distinguished Professor Emeritus of Pharmacology and Medicine at University of California, San Diego.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Paul Insel

University of California, San Diego

Distinguished Professor Emeritus Distinguished Professor Emeritus of Pharmacology and Medicine

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Introduction to the Theme “Novel Therapeutics With the Potential to Advance Health Care”. The Annual Review of Pharmacology and Toxicology (2024)

Paul A. InselSusan G. AmaraAmrita Ahluwalia

toxicologynovel therapeuticshealth carenovel therapiestherapeutic approachespharmacologypharmacotherapytherapeutic efficacy

Mindfulness Coaching With Digital Lifestyle Monitoring Enhances Selective Attention in Medical Scientists. medRxiv (Cold Spring Harbor Laboratory) (2024)

Satish JaiswalJason NanSuzanna R. PurpuraJames K. ManchandaIris Garcia-pakDhakshin S. RamanathanDawna ChussDeborah T. RanaEllen BeckPaul A. InselNeil ChiDavid M. RothHemal H. PatelJyoti Mishra

mental healthmedical scientistshealth informaticsattentionbehavioral medicinehealth technologymedicineapplied cognitive psychologyhealth sciencesbehavioral sciencesclinical psychology

Pancreatic Ductal Adenocarcinoma, β-Blockers, and Antihistamines: A Clinical Trial is Needed. Function (2024)

Jillian G BakerErica K SloanKevin PflegerPeter J McCormickCristina SalmerónPaul A Insel

Bjp Recommendations for Publishing Research on Tobacco Smoke and Environmental Tobacco Smoke Exposure. British Journal of Pharmacology (2023)

RA PanettieriSC StanfordS AlexanderG CirinoCH GeorgePA Insel...

public healthtobacco smokeresearch ethicstobacco controlpharmacologybjp recommendationshealth sciences

Considering and Reporting Sex as an Experimental Variable II: An Update on Progress in the British Journal of Pharmacology. British Journal of Pharmacology (2023)

experimental variable iiexperimental analysispharmacologysex differencesstatistics

Gpcr Signaling Measurement and Drug Profiling With an Automated Live-Cell Microscopy System. ACS Sensors (2023)

Eric GreenwaldClara PosnerAnanya BharathAnne LyonsCristina SalmerónKrishna SriramShu Z. WileyPaul A. InselJin Zhang

proteomicscell signalinghealth technologydrug profilingpharmacologysensor technologyinstrumentation

Introduction to the Theme “Pharmacological Individuality: New Insights and Strategies for Personalized and Precise Drug Treatment”. The Annual Review of Pharmacology and Toxicology (2023)

Urs A. MeyerSusan G. AmaraTerrence F. BlaschkePaul A. Insel

Isid1004 - Dermal Extracellular Matrix Inhibits Mast Cell Activation to Skin Commensal Bacteria. (2023)

Anna Di NardoShahrzad AlimohammadiKana Masuda-KurokiYu-Ling ChangPaul Insel

extracellular matrixcommensal bacteriadermatology

Mast Cell Tolerance in the Skin Microenvironment to Commensal Bacteria is Controlled by Fibroblasts. Cell Reports (2023)

Anna Di NardoYu-Ling ChangShahrzad AlimohammadiKana Masuda-KurokiZhenping WangKrishna SriramPaul A. Insel

microbiologybacteriacutaneous biologymast cell toleranceskin microenvironment

Ramipril for the Treatment of Covid-19: Ramic, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Advances in Therapy (2023)

infectious diseasesplacebo-controlled clinical trialhematologyantiviral therapypharmacologymedicinecovid-19pharmacotherapyclinical trials

1
2
3
4
5
58
10 / page

Similar Faculty Members

Gary Johnson

Institution

University of North Carolina at Chapel Hill

mapk kinase

apoptosis

Daria Mochly-Rosen

Institution

Stanford University

pharmacology

cardiology

Tadashi Inagami

Institution

Vanderbilt University

cardiovascular disease

hypertension

Asrar B Malik, PhD

Institution

University of Illinois Chicago

endothelial cell biology

immunology

Walter J. Koch

Institution

Duke University

cardiology

cardiovascular research

Sushil Mahata

Institution

University of California, San Diego

metabolic disorder

hormone secretion

John Griffin

Institution

University of California, San Diego

hemostasis

protein science

Mark Donowitz

Institution

Johns Hopkins University

pharmacology

gastroenterology

Yusuf Hannun

Institution

Stony Brook University

lipid movement

plasma membrane proteins

Sarah Spiegel

Institution

Virginia Commonwealth University

signaling pathway

cancer cell

Similar Faculty Members

Gary Johnson

Institution

University of North Carolina at Chapel Hill

mapk kinase

apoptosis

Daria Mochly-Rosen

Institution

Stanford University

pharmacology

cardiology

Tadashi Inagami

Institution

Vanderbilt University

cardiovascular disease

hypertension

Asrar B Malik, PhD

Institution

University of Illinois Chicago

endothelial cell biology

immunology

Walter J. Koch

Institution

Duke University

cardiology

cardiovascular research

Sushil Mahata

Institution

University of California, San Diego

metabolic disorder

hormone secretion

John Griffin

Institution

University of California, San Diego

hemostasis

protein science

Mark Donowitz

Institution

Johns Hopkins University

pharmacology

gastroenterology

Yusuf Hannun

Institution

Stony Brook University

lipid movement

plasma membrane proteins

Sarah Spiegel

Institution

Virginia Commonwealth University

signaling pathway

cancer cell